Green tea and breast cancer

Molecular Nutrition and Food Research

Volumn 55, Issue 6, 2011, Pages 921-930

  Wu, Anna H ^a   Butler, Lesley M ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Department of Ecosystem Science and Sustainability   (United States)

Author keywords

Breast cancer; Circulating hormone levels; Green tea; Insulin like growth factor; Mammographic density

Indexed keywords

ADIPONECTIN; ANDROGEN; ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; CATECHIN; ESTROGEN; PLANT EXTRACT; SOMATOMEDIN;

ANIMAL; BLOOD; BREAST TUMOR; CHEMISTRY; FEMALE; HUMAN; MAMMOGRAPHY; PHYTOTHERAPY; RADIOGRAPHY; REVIEW; RISK; TEA;

ADIPONECTIN; ANDROGENS; ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOLOGICAL MARKERS; BREAST NEOPLASMS; CATECHIN; ESTROGENS; FEMALE; HUMANS; MAMMOGRAPHY; PHYTOTHERAPY; PLANT EXTRACTS; RISK; SOMATOMEDINS; TEA;

ANIMALIA;

EID: 79958058693     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201100006     Document Type: Review

References (74)

1. Parkin, D. M., Bray, F., Ferlay, J., Pisani, P., Global cancer statistics, 2002. CA Cancer J. Clin. 2005, 55, 74-108.
2. Ogunleye, A. A., Xue, F., Michels, K. B., Green tea consumption and breast cancer risk or recurrence: a meta-analysis. Breast Cancer Res. Treat. 2010, 119, 477-484.
3. Seely, D., Mills, E. J., Wu, P., Verma, S., Guyatt, G. H., The effects of green tea consumption on incidence of breast cancer and recurrence of breast cancer: a systematic review and meta-analysis. Integr. Cancer Ther. 2005, 4, 144-155.
4. Sun, C. L., Yuan, J. M., Koh, W. P., Yu, M. C., Green tea, black tea and breast cancer risk: a meta-analysis of epidemiological studies. Carcinogenesis 2006, 27, 1310-1315.
5. Yang, C. S., Wang, X., Lu, G., Picinich, S. C., Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat. Rev. Cancer 2009, 9, 429-439.
6. Satoh, K., Sakamoto, Y., Ogata, A., Nagai, F. et al., Inhibition of aromatase activity by green tea extract catechins and their endocrinological effects of oral administration in rats. Food Chem. Toxicol. 2002, 40, 925-933.
7. Goodin, M. G., Rosengren, R. J., Epigallocatechin gallate modulates CYP450 isoforms in the female Swiss-Webster mouse. Toxicol. Sci. 2003, 76, 262-270.
8. Kao, Y. H., Hiipakka, R. A., Liao, S., Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Endocrinology 2000, 141, 980-987.
9. Shrubsole, M. J., Lu, W., Chen, Z., Shu, X. O. et al., Drinking green tea modestly reduces breast cancer risk. J. Nutr. 2009, 139, 310-316.
10. Wu, A. H., Yu, M. C., Tseng, C. C., Hankin, J., Pike, M. C., Green tea and risk of breast cancer in Asian Americans. Int. J. Cancer 2003, 106, 574-579.
11. Zhang, M., Holman, C. D., Huang, J. P., Xie, X., Green tea and the prevention of breast cancer: a case-control study in Southeast China. Carcinogenesis 2007, 28, 1074-1078.
12. Wu, A. H., Yu, M. C., Tseng, C. C., Pike, M. C., Body size, hormone therapy and risk of breast cancer in Asian-American women. Int. J. Cancer 2007, 120, 844-852.
13. Iwasaki, M., Inoue, M., Sasazuki, S., Sawada, N. et al., Green tea drinking and subsequent risk of breast cancer in a population to based cohort of Japanese women. Breast Cancer Res. 2010, 12, R88.
14. Nagano, J., Kono, S., Preston, D. L., Mabuchi, K., A prospective study of green tea consumption and cancer incidence, Hiroshima and Nagasaki (Japan). Canc. Causes Contr. 2001, 12, 501-508.
15. Suzuki, Y., Tsubono, Y., Nakaya, N., Koizumi, Y., Tsuji, I., Green tea and the risk of breast cancer: pooled analysis of two prospective studies in Japan. Br. J. Cancer 2004, 90, 1361-1363.
16. Yuan, J. M., Koh, W. P., Sun, C. L., Lee, H. P., Yu, M. C., Green tea intake, ACE gene polymorphism and breast cancer risk among Chinese women in Singapore. Carcinogenesis 2005, 26, 1389-1394.
17. Inoue, M., Robien, K., Wang, R., Van Den Berg, D. J. et al., Green tea intake, MTHFR/TYMS genotype and breast cancer risk: the Singapore Chinese Health Study. Carcinogenesis 2008, 29, 1967-1972.
18. Dai, Q., Shu, X. O., Li, H., Yang, G. et al., Is green tea drinking associated with a later onset of breast cancer? Ann. Epidemiol. 2010, 20, 74-81.
19. Stuart, E. C., Scandlyn, M. J., Rosengren, R. J., Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer. Life Sci. 2006, 79, 2329-2336.
20. Iwasaki, M., Inoue, M., Sasazuki, S., Miura, T. et al., Plasma tea polyphenol levels and subsequent risk of breast cancer among Japanese women: a nested case-control study. Breast Cancer Res. Treat. 2010, 124, 827-834.
21. Chow, H. H., Cai, Y., Hakim, I. A., Crowell, J. A. et al., Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin. Cancer Res. 2003, 9, 3312-3319.
22. Lee, M. J., Maliakal, P., Chen, L., Meng, X. et al., Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol. Biomarkers Prev. 2002, 11, 1025-1032.
23. Henning, S. M., Niu, Y., Lee, N. H., Thames, G. D. et al., Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement. Am. J. Clin. Nutr. 2004, 80, 1558-1564.
24. Luo, J., Gao, Y. T., Chow, W. H., Shu, X. O. et al., Urinary polyphenols and breast cancer risk: results from the Shanghai Women's Health Study. Breast Cancer Res. Treat. 2010, 120, 693-702.
25. Zhu, B. T., Patel, U. K., Cai, M. X., Conney, A. H., O-Methylation of tea polyphenols catalyzed by human placental cytosolic catechol-O-methyltransferase. Drug Metab. Dispos. 2000, 28, 1024-1030.
26. Zhu, B. T., Patel, U. K., Cai, M. X., Lee, A. J., Conney, A. H., Rapid conversion of tea catechins to monomethylated products by rat liver cytosolic catechol-O-methyltransferase. Xenobiotica 2001, 31, 879-890.
27. Wu, A. H., Tseng, C. C., Van Den Berg, D., Yu, M. C., Tea intake, COMT genotype, and breast cancer in Asian-American women. Cancer Res. 2003, 63, 7526-7529.
28. Nakachi, K., Suemasu, K., Suga, K., Takeo, T. et al., Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn. J. Cancer Res. 1998, 89, 254-261.
29. Inoue, M., Tajima, K., Mizutani, M., Iwata, H. et al., Regular consumption of green tea and the risk of breast cancer recurrence: follow-up study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC), Japan. Cancer Lett. 2001, 167, 175-182.
30. Key, T., Appleby, P., Barnes, I., Reeves, G., Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J. Natl. Cancer Inst. 2002, 94, 606-616.
31. Key, T. J., Appleby, P. N., Reeves, G. K., Roddam, A. et al., Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J. Natl. Cancer Inst. 2003, 95, 1218-1226.
32. Hankinson, S. E., Eliassen, A. H., Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer risk. J. Steroid Biochem. Mol. Biol. 2007, 106, 24-30.
33. Dorgan, J. F., Stanczyk, F. Z., Kahle, L. L., Brinton, L. A., Prospective case-control study of premenopausal serum estradiol and testosterone levels and breast cancer risk. Breast Cancer Res. 2010, 12, R98.
34. Farabegoli, F., Barbi, C., Lambertini, E., Piva, R., (-)-Epigallocatechin-3-gallate downregulates estrogen receptor alpha function in MCF-7 breast carcinoma cells. Cancer Detect. Prev. 2007, 31, 499-504.
35. Komori, A., Yatsunami, J., Okabe, S., Abe, S. et al., Anticarcinogenic activity of green tea polyphenols. Jpn. J. Clin. Oncol. 1993, 23, 186-190.
36. Ren, F., Zhang, S., Mitchell, S. H., Butler, R., Young, C. Y., Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells. Oncogene 2000, 19, 1924-1932.
37. Nagai, M., Conney, A. H., Zhu, B. T., Strong inhibitory effects of common tea catechins and bioflavonoids on the O-methylation of catechol estrogens catalyzed by human liver cytosolic catechol-o-methyltransferase. Drug Metab. Dispos. 2004, 32, 497-504.
38. Nagata, C., Kabuto, M., Shimizu, H., Association of coffee, green tea, and caffeine intakes with serum concentrations of estradiol and sex hormone-binding globulin in premenopausal Japanese women. Nutr. Cancer 1998, 30, 21-24.
39. Wu, A. H., Arakawa, K., Stanczyk, F. Z., Van Den Berg, D. et al., Tea and circulating estrogen levels in postmenopausal Chinese women in Singapore. Carcinogenesis 2005, 26, 976-980.
40. Wu, A. H., Yu, M. C., Tea, hormone-related cancers and endogenous hormone levels. Mol. Nutr. Food Res. 2006, 50, 160-169.
41. Wu, A. H., Yu, M. C., Tseng, C. C., Stanczyk, F. Z., Pike, M. C., Dietary patterns and breast cancer risk in Asian American women. Am. J. Clin. Nutr. 2009, 89, 1145-1154.
42. Boyd, N. F., Lockwood, G. A., Byng, J. W., Tritchler, D. L., Yaffe, M. J., Mammographic densities and breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 1998, 7, 1133-1144.
43. Boyd, N. F., Rommens, J. M., Vogt, K., Lee, V. et al., Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol. 2005, 6, 798-808.
44. Hawes, D., Downey, S., Pearce, C. L., Bartow, S. et al., Dense breast stromal tissue shows greatly increased concentration of breast epithelium but no increase in its proliferative activity. Breast Cancer Res. 2006, 8, R24.
45. Leong, H., Mathur, P. S., Greene, G. L., Inhibition of mammary tumorigenesis in the C3(1)/SV40 mouse model by green tea. Breast Cancer Res. Treat. 2008, 107, 359-369.
46. Wu, A. H., Ursin, G., Koh, W. P., Wang, R. et al., Green tea, soy, and mammographic density in singapore chinese women. Cancer Epidemiol. Biomarkers Prev. 2008, 17, 3358-3365.
47. Hankin, J. H., Stram, D. O., Arakawa, K., Park, S. et al., Singapore Chinese Health Study: development, validation, and calibration of the quantitative food frequency questionnaire. Nutr. Cancer 2001, 39, 187-195.
48. Pollak, M. N., Schernhammer, E. S., Hankinson, S. E., Insulin-like growth factors and neoplasia. Nat. Rev. Cancer 2004, 4, 505-518.
49. Key, T. J., Appleby, P. N., Reeves, G. K., Roddam, A. W., Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol. 2010, 11, 530-542.
50. Zhou, J. R., Yu, L., Mai, Z., Blackburn, G. L., Combined inhibition of estrogen-dependent human breast carcinoma by soy and tea bioactive components in mice. Int. J. Cancer 2004, 108, 8-14.
51. Maruyama, K., Iso, H., Ito, Y., Watanabe, Y. et al., Associations of food and nutrient intakes with serum IGF-I, IGF-II, IGFBP-3, TGF-b1, total SOD activity and sFas levels among middle-aged Japanese: the Japan Collaborative Cohort study. Asian Pac. J. Cancer Prev. 2009, 10, 7-22.
52. Swarbrick, M. M., Havel, P. J., Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans. Metab. Syndr. Relat. Disord. 2008, 6, 87-102.
53. Barb, D., Williams, C. J., Neuwirth, A. K., Mantzoros, C. S., Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. Am. J. Clin. Nutr. 2007, 86, s858-866.
54. Tworoger, S. S., Eliassen, A. H., Kelesidis, T., Colditz, G. A. et al., Plasma adiponectin concentrations and risk of incident breast cancer. J. Clin. Endocrinol. Metab. 2007, 92, 1510-1516.
55. Gaudet, M. M., Falk, R. T., Gierach, G. L., Lacey, J. V., Jr et al., Do adipokines underlie the association between known risk factors and breast cancer among a cohort of United States women? Cancer Epidemiol. 2010, 34, 580-586.
56. Cust, A. E., Stocks, T., Lukanova, A., Lundin, E. et al., The influence of overweight and insulin resistance on breast cancer risk and tumour stage at diagnosis: a prospective study. Breast Cancer Res. Treat. 2009, 113, 567-576.
57. Cho, S. Y., Park, P. J., Shin, H. J., Kim, Y. K. et al., (-)-Catechin suppresses expression of Kruppel-like factor 7 and increases expression and secretion of adiponectin protein in 3T3-L1 cells. Am. J. Physiol. Endocrinol. Metab. 2007, 292, E1166-E1172.
58. Basu, A., Du, M., Sanchez, K., Leyva, M. J. et al., Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome. Nutrition 2010, 27, 206-213.
59. Imatoh, T., Tanihara, S., Miyazaki, M., Momose, Y. et al., Coffee consumption but not green tea consumption is associated with adiponectin levels in Japanese males. Eur. J. Nutr. 2010, DOI 10.1007/s00394-010-0136-5.
60. Wu, A. H., Yu., M. C., Stanczyk, F., Tseng, C. C., Pike, M. C., Anthropometric, dietary and hormonal correlates of serum adiponectin in Asian American women. Nutr. Canc., 2011, (in press).
61. Crespy, V., Williamson, G., A review of the health effects of green tea catechins in in vivo animal models. J. Nutr. 2004, 134, 3431S-3440S.
62. Hirose, M., Mizoguchi, Y., Yaono, M., Tanaka, H. et al., Effects of green tea catechins on the progression or late promotion stage of mammary gland carcinogenesis in female Sprague-Dawley rats pretreated with 7, 12-dimethylbenz(a)anthracene. Cancer Lett. 1997, 112, 141-147.
63. Tanaka, H., Hirose, M., Kawabe, M., Sano, M. et al., Post-initiation inhibitory effects of green tea catechins on 7, 12-dimethylbenz[a]anthracene-induced mammary gland carcinogenesis in female Sprague-Dawley rats. Cancer Lett. 1997, 116, 47-52.
64. Baliga, M. S., Meleth, S., Katiyar, S. K., Growth inhibitory and antimetastatic effect of green tea polyphenols on metastasis-specific mouse mammary carcinoma 4T1 cells in vitro and in vivo systems. Clin. Cancer Res. 2005, 11, 1918-1927.
65. Kaur, S., Greaves, P., Cooke, D. N., Edwards, R. et al., Breast cancer prevention by green tea catechins and black tea theaflavins in the C3(1) SV40 T, t antigen transgenic mouse model is accompanied by increased apoptosis and a decrease in oxidative DNA adducts. J. Agric. Food Chem. 2007, 55, 3378-3385.
66. Liao, S., Umekita, Y., Guo, J., Kokontis, J. M., Hiipakka, R. A., Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate. Cancer Lett. 1995, 96, 239-243.
67. Sartippour, M. R., Shao, Z. M., Heber, D., Beatty, P. et al., Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells. J. Nutr. 2002, 132, 2307-2311.
68. Thangapazham, R. L., Singh, A. K., Sharma, A., Warren, J. et al., Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Cancer Lett. 2007, 245, 232-241.
69. Sartippour, M. R., Pietras, R., Marquez-Garban, D. C., Chen, H. W. et al., The combination of green tea and tamoxifen is effective against breast cancer. Carcinogenesis 2006, 27, 2424-2433.
70. Chisholm, K., Bray, B. J., Rosengren, R. J., Tamoxifen and epigallocatechin gallate are synergistically cytotoxic to MDA-MB-231 human breast cancer cells. Anticancer Drugs 2004, 15, 889-897.
71. Eddy, S. F., Kane, S. E., Sonenshein, G. E., Trastuzumab-resistant HER2-driven breast cancer cells are sensitive to epigallocatechin-3 gallate. Cancer Res. 2007, 67, 9018-9023.
72. Li, Y., Yuan, Y. Y., Meeran, S. M., Tollefsbol, T. O., Synergistic epigenetic reactivation of estrogen receptor-alpha (ERalpha) by combined green tea polyphenol and histone deacetylase inhibitor in ERalpha-negative breast cancer cells. Mol. Cancer 2010, 9, 274.
73. Bhide, S. V., Azuine, M. A., Lahiri, M., Telang, N. T., Chemoprevention of mammary tumor virus-induced and chemical carcinogen-induced rodent mammary tumors by natural plant products. Breast Cancer Res. Treat. 1994, 30, 233-242.
74. Kavanagh, K. T., Hafer, L. J., Kim, D. W., Mann, K. K. et al., Green tea extracts decrease carcinogen-induced mammary tumor burden in rats and rate of breast cancer cell proliferation in culture. J. Cell Biochem. 2001, 82, 387-398.